<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35692305</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>08</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>A Prediction Model for Peak Expiratory Flow Derived From Venous Blood Biomarkers and Clinical Factors in Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>899027</StartPage><MedlinePgn>899027</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">899027</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2022.899027</ELocationID><Abstract><AbstractText>Although peripheral venous blood biomarkers are related to respiratory function in Amyotrophic lateral sclerosis (ALS) patients, there are still few prediction models that predict pulmonary function. This study aimed to investigate the venous blood biomarkers associated with respiratory function in patients with ALS from southwest China and to create prediction models based on those clinical biomarkers using logistic regression. A total of 319 patients with ALS from the retrospective cohort and 97 patients with ALS from the prospective cohort were enrolled in this study. A multivariable prediction model for the correlation between peak expiratory flow (PEF) and hematologic, biochemical laboratory parameters, and clinical factors in patients with ALS was created. Along with female patients, bulbar-onset, lower body mass index (BMI), later age of onset, lower level of creatinine, uric acid, triglyceride, and a higher level of high-density lipoprotein cholesterol (HDL_C) were related to reduced PEF. The area under the receiver operating characteristics (ROC) curve is.802 for the test set and.775 for the validation set. The study constructed a multivariable prediction model for PEF in patients with ALS. The results can be helpful for clinical practice to predict respiratory impairment.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 He, Feng, Cong, Huang, Zhao, Shen, Xu and Xu.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>He</LastName><ForeName>Xianghua</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Jiangbin Hospital, Nanning, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Jiaming</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>West China Clinical Medical College, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cong</LastName><ForeName>Xue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>West China School of Public Health, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Hongyan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Quanzhen</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Qiuyan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Yanming</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="Y">Respiratory Insufficiency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">peak expiratory flow</Keyword><Keyword MajorTopicYN="N">prediction model</Keyword><Keyword MajorTopicYN="N">respiratory function</Keyword><Keyword MajorTopicYN="N">venous blood parameters</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>13</Day><Hour>2</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35692305</ArticleId><ArticleId IdType="pmc">PMC9184518</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2022.899027</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kiernan M, Vucic S, Talbot K, McDermott C, Hardiman O, Shefner J, et al. . Improving clinical trial outcomes in amyotrophic lateral sclerosis. Nat Rev Neurol. (2021) 17:104&#x2013;18. 10.1038/s41582-020-00434-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-00434-z</ArticleId><ArticleId IdType="pmc">PMC7747476</ArticleId><ArticleId IdType="pubmed">33340024</ArticleId></ArticleIdList></Reference><Reference><Citation>Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. (2019) 32:771&#x2013;6. 10.1097/WCO.0000000000000730</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000730</ArticleId><ArticleId IdType="pmc">PMC6735526</ArticleId><ArticleId IdType="pubmed">31361627</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr E, Logroscino G, Robberecht W, et al. . Amyotrophic lateral sclerosis. Nat Rev Dis primers. (2017) 3:17071. 10.1038/nrdp.2017.71</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P, Abrahams S, Borasio G, de Carvalho M, Chio A, Van Damme P, et al. . EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)&#x2013;revised report of an EFNS task force. Eur J Neurol. (2012) 19:360&#x2013;75. 10.1111/j.1468-1331.2011.03501.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03501.x</ArticleId><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin D, Meltzer E, Pisternick-Ruf W, Moroni-Zentgraf P, Engel M, Zaremba-Pechmann L, et al. . Peak expiratory flow as an endpoint for clinical trials in asthma: a comparison with FEV. Respir Res. (2019) 20:159. 10.1186/s12931-019-1119-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-019-1119-6</ArticleId><ArticleId IdType="pmc">PMC6637596</ArticleId><ArticleId IdType="pubmed">31319851</ArticleId></ArticleIdList></Reference><Reference><Citation>Onesti E, Schettino I, Gori M, Frasca V, Ceccanti M, Cambieri C, et al. . Dysphagia in amyotrophic lateral sclerosis: impact on patient behavior, diet adaptation, and riluzole management. Front Neurol. (2017) 8:94. 10.3389/fneur.2017.00094</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00094</ArticleId><ArticleId IdType="pmc">PMC5359548</ArticleId><ArticleId IdType="pubmed">28377742</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabor L, Gaziano J, Watts S, Robison R, Plowman E. Defining swallowing-related quality of life profiles in individuals with amyotrophic lateral sclerosis. Dysphagia. (2016) 31:376&#x2013;82. 10.1007/s00455-015-9686-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00455-015-9686-2</ArticleId><ArticleId IdType="pmc">PMC4871719</ArticleId><ArticleId IdType="pubmed">26837611</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G, Su J, Wang X, He J. Value of peak expiratory flow rate in evaluating cough ability in patients undergoing lung surgery. Can Respir J. (2021) 2021:5888783. 10.1155/2021/5888783</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/5888783</ArticleId><ArticleId IdType="pmc">PMC8695022</ArticleId><ArticleId IdType="pubmed">34956429</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Zhou Y, Gao S, Du C, Yao L, Yang R. Effects of preoperative pulmonary function on short-term outcomes and overall survival after video-assisted thoracic surgery lobectomy. Ann Transl Med. (2021) 9:1651. 10.21037/atm-21-5244</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm-21-5244</ArticleId><ArticleId IdType="pmc">PMC8667134</ArticleId><ArticleId IdType="pubmed">34988160</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang S, Zhou K, Wang Y, Lai Y, Che G. Prognostic value of preoperative peak expiratory flow to predict postoperative pulmonary complications in surgical lung cancer patients. Front Oncol. (2021) 11:782774. 10.3389/fonc.2021.782774</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2021.782774</ArticleId><ArticleId IdType="pmc">PMC8645567</ArticleId><ArticleId IdType="pubmed">34881188</ArticleId></ArticleIdList></Reference><Reference><Citation>Borders J, Troche M. voluntary cough effectiveness and airway clearance in neurodegenerative disease. J Speech Lang Hear Res. (2021).65:431&#x2013;49 10.1044/2021_JSLHR-21-00308</Citation><ArticleIdList><ArticleId IdType="doi">10.1044/2021_JSLHR-21-00308</ArticleId><ArticleId IdType="pubmed">34936376</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabor-Gray L, Vasilopoulos T, Wheeler-Hegland K, Wymer J, Plowman E. Reflexive airway sensorimotor responses in individuals with amyotrophic lateral sclerosis. Dysphagia. (2021) 36:574&#x2013;82. 10.1007/s00455-020-10171-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00455-020-10171-6</ArticleId><ArticleId IdType="pubmed">32778945</ArticleId></ArticleIdList></Reference><Reference><Citation>plowman e, watts s, robison r, tabor l, dion c, gaziano j, et al. . voluntary cough airflow differentiates safe vs. unsafe swallowing in amyotrophic lateral sclerosis. Dysphagia. (2016) 31:383&#x2013;90. 10.1007/s00455-015-9687-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00455-015-9687-1</ArticleId><ArticleId IdType="pmc">PMC4871758</ArticleId><ArticleId IdType="pubmed">26803772</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirola A, De Mattia E, Lizio A, Sannicol&#xf2; G, Carraro E, Rao F, et al. . The prognostic value of spirometric tests in Amyotrophic Lateral Sclerosis patients. Clin Neurol Neurosurg. (2019) 184:105456. 10.1016/j.clineuro.2019.105456</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2019.105456</ArticleId><ArticleId IdType="pubmed">31382080</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Huang J, Chen J, Hu W, Xu L, Guo Q. Peak expiratory flow is a reliably household pulmonary function parameter correlates with disease severity and survival of patients with amyotrophic lateral sclerosis. BMC Neurol. (2022) 22:105. 10.1186/s12883-022-02635-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-022-02635-z</ArticleId><ArticleId IdType="pmc">PMC8933978</ArticleId><ArticleId IdType="pubmed">35305605</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Calvo A, Ilardi A, Cavallo E, Moglia C, Mutani R, et al. . Lower serum lipid levels are related to respiratory impairment in patients with ALS. Neurology. (2009) 73:1681&#x2013;5. 10.1212/WNL.0b013e3181c1df1e</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181c1df1e</ArticleId><ArticleId IdType="pubmed">19917991</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda K, Hirayama T, Takazawa T, Kawabe K, Iwasaki Y. Relationships between disease progression and serum levels of lipid, urate, creatinine and ferritin in Japanese patients with amyotrophic lateral sclerosis: a cross-sectional study. Int Med. (2012) 51:1501&#x2013;8. 10.2169/internalmedicine.51.7465</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.51.7465</ArticleId><ArticleId IdType="pubmed">22728481</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Calvo A, Bovio G, Canosa A, Bertuzzo D, Galmozzi F, et al. . Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study. JAMA Neurol. (2014) 71:1134&#x2013;42. 10.1001/jamaneurol.2014.1129</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.1129</ArticleId><ArticleId IdType="pubmed">25048026</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eijk R, Eijkemans M, Ferguson T, Nikolakopoulos S, Veldink J, van den Berg L. Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials. J Neurol Neurosurg Psychiatry. (2018) 89:156&#x2013;61. 10.1136/jnnp-2017-317077</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317077</ArticleId><ArticleId IdType="pmc">PMC5800333</ArticleId><ArticleId IdType="pubmed">29084868</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;ffner R, Zach N, Norel R, Hawe J, Schoenfeld D, Wang L, et al. . Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression. Nat Biotechnol. (2015) 33:51&#x2013;7. 10.1038/nbt.3051</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3051</ArticleId><ArticleId IdType="pubmed">25362243</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. (2000) 1:293&#x2013;9. 10.1080/146608200300079536</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Al-Chalabi A, Filippi M, Hardiman O, Kaji R, Meininger V, et al. . The El Escorial criteria: strengths and weaknesses. Amyotroph Lateral Scler Frontotemporal Degener. (2015) 16:1&#x2013;7. 10.3109/21678421.2014.964258</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.964258</ArticleId><ArticleId IdType="pubmed">25482030</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgadinho J, Pronto-Laborinho A, Concei&#xe7;&#xe3;o V, Gromicho M, Pinto S, Swash M, et al. . Plasma creatinine level does not predict respiratory function in amyotrophic lateral sclerosis. J Neuromuscul Dis. (2021) 8:795&#x2013;9. 10.3233/JND-200583</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JND-200583</ArticleId><ArticleId IdType="pubmed">33646173</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada S, Hashizume A, Hijikata Y, Inagaki T, Suzuki K, Kondo N, et al. . Decreased peak expiratory flow associated with muscle fiber-type switching in spinal and bulbar muscular atrophy. PLoS ONE. (2016) 11:e0168846. 10.1371/journal.pone.0168846</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0168846</ArticleId><ArticleId IdType="pmc">PMC5179045</ArticleId><ArticleId IdType="pubmed">28005993</ArticleId></ArticleIdList></Reference><Reference><Citation>Enache I, Pistea C, Fleury M, Schaeffer M, Oswald-Mammosser M, Echaniz-Laguna A, et al. . Ability of pulmonary function decline to predict death in amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener. (2017) 18:511&#x2013;8. 10.1080/21678421.2017.1353097</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1353097</ArticleId><ArticleId IdType="pubmed">28728441</ArticleId></ArticleIdList></Reference><Reference><Citation>Tilanus T, Groothuis J, TenBroek-Pastoor J, Feuth T, Heijdra Y, Slenders J, et al. . The predictive value of respiratory function tests for non-invasive ventilation in amyotrophic lateral sclerosis. Respir Res. (2017) 18:144. 10.1186/s12931-017-0624-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-017-0624-8</ArticleId><ArticleId IdType="pmc">PMC5526316</ArticleId><ArticleId IdType="pubmed">28743265</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Hu W, Guo Q, Xu G, Wang N, Zhang Q. Serum Uric Acid Levels Predict Mortality Risk in Male Amyotrophic Lateral Sclerosis Patients. Front Neurol. (2021) 12:602663. 10.3389/fneur.2021.602663</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.602663</ArticleId><ArticleId IdType="pmc">PMC7991582</ArticleId><ArticleId IdType="pubmed">33776880</ArticleId></ArticleIdList></Reference><Reference><Citation>Moglia C, Calvo A, Grassano M, Canosa A, Manera U, D'Ovidio F, et al. . Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort. J Neurol Neurosurg Psychiatry. (2019) 90:666&#x2013;73. 10.1136/jnnp-2018-319611</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319611</ArticleId><ArticleId IdType="pubmed">30630957</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli J, Malerba S, Beghi E, Fini N, Fasano A, Zucchi E, et al. . Riluzole and other prognostic factors in ALS: a population-based registry study in Italy. J Neurol. (2018) 265:817&#x2013;27. 10.1007/s00415-018-8778-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-8778-y</ArticleId><ArticleId IdType="pubmed">29404735</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto S, de Carvalho M. Comparison of slow and forced vital capacities on ability to predict survival in ALS. Amyotroph Lateral Scler Frontotemporal Degener. (2017) 18:528&#x2013;33. 10.1080/21678421.2017.1354995</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1354995</ArticleId><ArticleId IdType="pubmed">28741375</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>